Xilio Therapeutics, Inc. (XLO)

Last Closing Price: 0.69 (2025-08-28)

Days Sales in Receivables (Quarterly)

Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover

Xilio Therapeutics, Inc. (XLO) Days Sales in Receivables data is not available.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
$8.08M
$-15.84M
--
$8.08M
$22.45M
$-14.37M
$-1.48M
$-15.84M
$-15.84M
$-15.84M
$-15.84M
$-15.84M
$-15.84M
$-14.37M
$-13.98M
96.45M
96.45M
$-0.16
$-0.16
Balance Sheet Financials
$123.72M
$4.02M
$10.10M
$133.81M
$53.26M
--
$73.48M
$126.74M
$7.07M
$7.07M
$7.07M
51.83M
Cash Flow Statement Financials
$14.50M
$-0.42M
$52.19M
$57.07M
$123.34M
$66.27M
$2.89M
--
--
Fundamental Metrics & Ratios
2.32
--
--
--
--
100.00%
-177.71%
-177.71%
--
-195.99%
-195.99%
$14.08M
--
--
--
0.06
--
--
Days Sales in Receivables
--
-224.13%
-224.13%
-11.84%
-224.13%
$0.14
$0.15
$0.15